Respivant RVT1601-CC-04 SCENIC: Randomized double blind placebo controlled dose ranging efficacy and safety study with inhaled RVT-1601 for the treatment of persistent cough in patients with IPF

Administered By

Awarded By

Contributors

Start/End

  • October 21, 2019 - October 14, 2020